Antioxidant enzymes and melatonin levels in patients with bronchial asthma and chronic obstructive pulmonary disease during stable and exacerbation periods

Cell Biochemistry and Function

Volumn 27, Issue 5, 2009, Pages 276-283

  Gumral, Nurhan ^a   Naziroglu, Mustafa ^a   Ongel, Kurtulus ^a   Beydilli, Emine Dasdibi ^b   Ozguner, Fehmi ^a   Sutcu, Recep ^a   Caliskan, Sadettin ^a   Akkaya, Ahmet ^a  

^a SULEYMAN DEMIREL UNIVERSITY SCHOOL OF MEDICINE   (Turkey)

^b SULEYMAN DEMIREL UNIVERSITY   (Turkey)

Author keywords

Antioxidant enzymes; Bronchial asthma; COPD; Exacerbation; Lipid peroxidation; Melatonin

Indexed keywords

ANTIOXIDANT; CATALASE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; MALONALDEHYDE; MELATONIN; SUPEROXIDE DISMUTASE; OXIDOREDUCTASE;

ADULT; AGED; ARTICLE; ASTHMA; BLOOD GAS ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE EXACERBATION; ENZYME ACTIVITY; EOSINOPHIL COUNT; ERYTHROCYTE; FEMALE; FORCED EXPIRATORY VOLUME; HORMONE BLOOD LEVEL; HUMAN; LEUKOCYTE COUNT; LIPID PEROXIDATION; MALE; OXIDATIVE STRESS; OXYGEN TENSION; PEAK EXPIRATORY FLOW; PH; PRIORITY JOURNAL; RESPIRATORY FUNCTION; BLOOD; DISEASE COURSE; ENZYMOLOGY; METABOLISM;

ANTIOXIDANTS; ASTHMA; CATALASE; DISEASE PROGRESSION; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; HUMANS; MALONDIALDEHYDE; MELATONIN; OXIDATIVE STRESS; OXIDOREDUCTASES; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SUPEROXIDE DISMUTASE;

EID: 70349254680     PISSN: 02636484     EISSN: 10990844     Source Type: Journal    
DOI: 10.1002/cbf.1569     Document Type: Article

References (43)

1. Honig EG, Ingram RH, Jr. Chronic bronchitis, emphysema and airway obstruction. In Harrison's Principles of Internal Medicine (14th ed), Fauci AS, Braunwald E, Isselbacher KJ, et al. (eds). McGraw-Hill Book Co: New York, 1998; 1451-1459.
2. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997; 349: 1498-1504.
3. Tekin D, Sin BA, Mungan D, Misirligil Z, Yavuzer S. The oxidative defense in asthma. J Asthma 2000; 37: 59-63.
4. Yamamoto C, Yoneda T, Yoshykawa M, et al. Airway inflammation in COPD assessed by sputum levels of interleukin-8. Chest 1997; 112: 505-510.
5. Stephen I, Rennard MD. Overview of causes of COPD: new understanding of pathogenesis and mechanisms can guide future therapy. Postgrad Med 2002; 111: 28-30.
6. Bai N, Khazaei M, Van Eeden SF, Laher I. The pharmacology of particulate matter air pollution-induced cardiovascular dysfunction. Pharmacol Ther 2007; 113: 16-29.
7. Rahman I. Antioxidant therapies in COPD. Int J Chron Obstruct Pulmon Dis 2006; 1: 15-29.
8. Manrique HA, Gómez FP, Muñoz PA, et al. Adenosine 5′-monophosphate in asthma: gas exchange and sputum cellular responses. Eur Respir J 2008; 31: 1205-1212.
9. Evaldsson C, Rydén I, Uppugunduri S. Anti-inflammatory effects of exogenous uridine in an animal model of lung inflammation. Int Immunopharmacol 2007; 7: 1025-1032.
10. Rahman I, Macnee W. Oxidant/antioxidant imbalance in smokers and chronic obstructive pulmonary diseases. Thoraks 1996; 51: 348-351.
11. Bachowski S, Kolâja KL, Xu Y, et al. Role of oxidative stress in the mechanism of dieldrin's hepatotoxicity. Ann Clin Lab Sci 1997; 27: 196-209.
12. Naziroǧlu M. New molecular mechanisms on the activation of TRPM2 channels by oxidative stress and ADP-ribose. Neurochem Res 2007; 2: 1990-2001.
13. Naziroǧlu M. Molecular mechanisms of vitamin E on intracellular signaling pathways in brain. In Reactive Oxygen Species and Diseases, Laszlo Goth, (ed.). Research Signpost Press: Kerala, India, 2007; 239-256.
14. Global Initiative for Asthma (GINA). Global strategy for asthma management and prevention. NHLBI/WHO Workshop Report. National Institute of Health. National Heart, Lung, and Blood Institute. Publication No: 02-3659, Revised 2002.
15. Pauwels RA, Buist AS, Calverley PM, Jenkins CR, Hurd SS. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. Am J Respir Crit Care Med 2001; 163: 1256-1276.
16. Draper HH, Hadley M. Malondialdehyde determination as index of lipid peroxidation. Meth Enzymol 1990; 186: 421-431.
17. Woolliams JA, Wiener G, Anderson PH, McMurray CH. Variation in the activities of glutathione peroxidase and superoxide dismutase and in the concentration of copper in the blood in various breed crosses of sheep. Res Vet Sci 1983; 34: 253-256.
18. Paglia DE, Valentine WN. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. J Lab Clin Med 1967; 70: 158-169.
19. Goldberg DM, Spooner RJ. Assay of glutathione reductase. In Methods of Enzymatic Analysis (3rd edn), Bergmeyer HV (ed.). Verlag Chemie Weinheim: Deerfield Beach, FL, 1983; 258-265.
20. Aebi H. Catalase. In Methods of Enzymatic Analysis, Bergmeyer HV (ed.). Academic Press: London and New York, 1974; 673-677.
21. Arendt J, Paunier L, Sizonenko PC. Melatonin radioimmunoassay. J Clin Endocrinol Metab 1975; 40: 347-350.
22. Bracke KR, Demedts IK, Joos GF, Brusselle GG. CC-chemokine receptors in chronic obstructive pulmonary disease. Inflamm Allergy Drug Targets 2007; 6: 75-79.
23. Vallyathan V, Xialnglin S. The role of oxygen free radicals in occupational and environmental lung diseases. Environ Health Prespect 1997; 105: 165-177.
24. Hanta I, Kocabas A, Canacankatan N, Kuleci S, Seydaoglu G. Oxidant-antioxidant balance in patients with COPD. Lung 2006; 184: 51-55.
25. Ito K, Herbert C, Siegle JS, et al. Steroid-resistant neutrophilic, inflammation in a mouse model of an acute exacerbation of asthma. Am J Respir Cell Mol Biol 2008; 39: 543-550.
26. Abboud RT, Vimalanathan S. Pathogenesis of COPD. Part I. The role of protease-antiprotease imbalance in emphysema. Rev Int J Tuberc Lung Dis 2008; 12: 361-367.
27. Suzuki S, Matsukura S, Takeuchi H, et al. Increase in reactive oxygen metabolite level in acute exacerbations of asthma. Int Arch Allergy Immunol 2008; 1: 67-72.
28. Sahin U, Unlu M, Ozgüner F, Sütçü R, Akkaya A, Delibas N. Lipid peroxidation and glutathione peroxidase activity in chronic obstructive pulmonary disease exacerbation: prognostic value of malondialdehyde. J Basic Clin Physiol Pharmacol 2001; 12: 59-68.
29. Tug T, Karatas F, Terzi SM. Antioxidant vitamins (A, C and E) and malondialdehyde levels in acute exacerbation and stable periods of patients with chronic obstructive pulmonary disease. Clin Invest Med 2004; 27: 123-128.
30. Daga M, Chhabra R, Sharma B. Effects of exogenous vitamin E supplementation on the levels of oxidants and antioxidants in chronic obstructive pulmonary disease. J Biosci 2003; 28: 7-11.
31. Rahman I, Biswas SK, Kode A. Oxidant and, antioxidant balance in the airways and airway diseases. Eur J Pharmacol 2006; 533: 222-239.
32. Roum JH, Aledia AS, Carungcong LA, Kim KJ, Borok Z. Extracellular glutathione inhibits oxygen-induced permeability changes in alveolar epithelial monolayers. J Appl Physiol 2001; 91: 748-754.
33. Liao MF, Chen CC, Hsu MH. Evaluation of the serum antioxidant status in asthmatic children. Acta Peadiatr Taiwan 2004; 45: 213-217.
34. Kinnula VL, Crapo JD. Superoxide dismutases in the lung and human lung diseases. Am J Respir Crit Care 2003; 167: 1600-1619.
35. Kurys E, Kurys P, Kuzniar A. Analysis of antioxidant enzyme activity and magnesium level in chronic obstructive pulmonary disease. Ann Univ Mariae Curie Sklodowska 2001; 56: 261-266.
36. Comhair SA, Xu W, Ghosh S, et al. Superoxide dismutase inactivation in pathophysiology of asthmatic airway remodeling and reactivity. Am J Pathol 2005; 166: 649-652.
37. Chang JC, van der Hoeven LH, Haddox CH. Glutathione reductase in the red blood cells. Ann Clin Lab Sci 1978; 8: 23-29.
38. Fitzpatrick AM, Teague WG, Holguin F, Yeh M, Brown LA. Severe asthma research program. Airway glutathione homeostasis is altered in children with severe asthma: evidence for oxidant stress. J Allergy Clin Immunol 2009; 123: 146-152. e8.
39. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its interactions. Endocr Rev 1991; 12: 152-170.
40. Luo F, Liu X, Li S, Liu C, Wang Z. Melatonin promoted chemotaxins expression in lung epithelial cell stimulated with TNF-alpha. Respir Res 2004; 5: 20.
41. Shafer LL, McNulty JA, Young MR. Assessment of melatonin's ability to regulate cytokine production by macrophage and microglia cell types. J Neuroimmunol 2001; 120: 84-93.
42. Lopes C, De Lyra JL, Markus RP, Maryano M. Circadian rhythm in experimental granulomatous inflammation is modulated by melatonin. J Pineal Res 1997; 23: 71-78.
43. Baydas G, Gursu MF, Yilmaz S, et al. Daily rhythm of glutathione peroxidase activity, lipid peroxidation and glutathione levels in tissues of pinealectomized rats. Neurosci Lett 2002; 323: 195-198.